Related Experiment Videos
Concealed medicines for people with schizophrenia: a U.S. perspective
Scott Stroup1, Marvin Swartz, Paul Appelbaum
1Department of Psychiatry, The University of North Carolina School of Medicine, Chapel Hill 27599-7160, USA. scott_stroup@med.unc.edu
Schizophrenia Bulletin
|March 21, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Treatment of Mental Disorders Among U.S. Adults: Findings From the Mental and Substance Use Disorders Prevalence Study.
Psychiatric services (Washington, D.C.)·2026
Impact of insurance type on outpatient mental health treatment of US adults.
PLOS mental health·2025
A Scoping Literature Review of Mental Illness in Decisions Regarding Pretrial Release.
The journal of the American Academy of Psychiatry and the Law·2025
Prevalence of Past-Year Mental and Substance Use Disorders, 2021-2022.
Psychiatric services (Washington, D.C.)·2025
Understanding Attention in Schizophrenia: The Enduring Influence of Barbara Cornblatt.
Schizophrenia bulletin·2026
Clinical Practice Guideline on the Pharmacological Management of Antipsychotic-Related Dyslipidemia.
Schizophrenia bulletin·2026
Common Medications Prescribed by Oral Medicine Practitioners in Saudi Arabia: A Cross-Sectional Study.
Journal of multidisciplinary healthcare·2026
Efficacy of dry needling in reducing spasticity after stroke: A systematic review and meta-analysis.
Complementary therapies in medicine·2026